ARC™ benefits

• Increases long-term survival rates by decreasing the frequency of organ rejection episodes
• Significantly expands the donor organ pool by diminishing the need for re-transplantations
• Reduces overall costs of organ transplantation by limiting complications and by increasing immunosuppressive drugs efficacy
• Allows organ transplantation to be a viable option to those who have been unable to find a donor match based on their “highly sensitized” condition
• Improved quality of life post-transplant by enhancing the effectiveness of traditional long-term anti-rejection therapy without creating secondary health conditions